OPK - CIK 0000944809
OPKO HEALTH, INC. trades as OPK and has a market capitalization of $1.11 B, making it the #2565 largest US-listed company by market value. This page tracks OPKO HEALTH, INC. through 0 SEC filings, with financial statements and metrics updated as new reports are filed.
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies :: OPKO Health, Inc. (OPK)
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform :: OPKO Health, Inc. (OPK)
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
OPKO HEALTH, INC. (OPK) has a market capitalization of $1.11 B as of 2026-05-29, ranking #2565 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas